J&J investor relations veep Mehrotra retires, Wolk steps up Johnson & Johnson (NYSE:JNJ) said today its 10-year vice president of investor relations Louise Mehrotra will retire, effective January 2017, to be replaced by Joseph Wolk, effective August 1. Wolk previously served as vice president of group finance for Johnson & Johnson’s pharmaceuticals deivision, and has […]
BSX pays $63m for Xlumena | The week in medtech M&A
Boston Scientific ponies up $63m for Xlumena
April 1, 2015 by Brad Perriello
Uroplasty, Vision-Sciences merge as Cogentix
MDT buys hearing aid maker Sophono | The week in medtech M&A
Medtronic buys hearing aid maker Sophono
March 26, 2015 by Brad Perriello
Uroplasty, Vision-Sciences shareholders OK merger
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Cardinal Health top suitor for J&J's Cordis unit
February 23, 2015 by Brian Johnson
Cigna to cover Uroplasty’s over-active bladder treatment
Health insurer Cigna has issued a positive coverage decision on Uroplasty’s (NSDQ:UPI) overactive bladder (OAB) treatment, Percutaneous Tibial Nerve Stimulation (PTNS).
Uroplasty, Vision-Sciences set date for merger vote
Uroplasty and Vision-Sciences shareholders will vote on the proposed all-stock merger deal between the two companies on March 30, according to a regulatory filing.